Rexahn announces pricing of public offering of common stock and warrants
Rexahn Pharmaceuticals announced pricing of an underwritten public offering of 10,750,000 shares of its common stock and warrants to purchase up to 10,750,000 shares of its common stock. Each share of common stock is being sold together in a fixed combination with a warrant. January 23, 2019